04/08/16 - 10:28 AM EDT
Clovis Oncology is better off if the U.S. Food and Drug Administration rejects its lung cancer drug rociletinib.
04/07/16 - 01:55 PM EDT
Relypsa has hired an investment bank and is exploring a sale following the receipt of offers from a "number of potential buyers," Reuters reports.
04/06/16 - 11:06 AM EDT
Both Allergan and Pfizer could target biotech and drug company acquisitions as a way to fuel future growth.
04/05/16 - 11:25 AM EDT
The extravagant travel-expense payouts to Provectus CEO Craig leaves the company at risk of criminal or civil investigations by the Securities and Exchange Commission.
04/04/16 - 11:54 AM EDT
Vertex's stock price has been cut almost in half since the cystic fibrosis drug Orkambi launched last summer.
04/04/16 - 08:50 AM EDT
Central to the Gilead purchase is a Nimbus compound with a novel mechanism of action targeting nonalcoholic steatohepatitis (NASH), better known as fatty liver disease.
04/04/16 - 06:30 AM EDT
Incomplete information from the AB Science trial makes it difficult to ascertain if ALS patient truly benefited from the company's lead compound masitinib.
04/03/16 - 09:00 AM EDT
TheStreet's Senior Columnist Adam Feuerstein answers reader questions about biotech stock investing.
04/01/16 - 11:27 AM EDT
A committee of European drug reviewers voted Friday to recommend the approval of the first oral treatment for Fabry disease, developed by Amicus Therapeutics.
03/29/16 - 12:36 PM EDT
A panel of outside experts selected by the FDA are reviewing a Parkinson's disease drug developed by Acadia Pharmaceuticals.